Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Uterine leiomyoma in a 13-year-old adolescent successfully treated with laparoscopic myomectomy: A case report.

Morita N, Tanaka T, Hashida S, Tsunetoh S, Taniguchi K, Komura K, Ohmichi M.

Medicine (Baltimore). 2019 Dec;98(49):e18301. doi: 10.1097/MD.0000000000018301.

2.

Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression.

Chakraborty G, Armenia J, Mazzu YZ, Nandakumar S, Stopsack KH, Atiq MO, Komura K, Jehane L, Hirani R, Chadalavada K, Yoshikawa Y, Khan NA, Chen Y, Abida W, Mucci LA, Lee GM, Nanjangud GJ, Kantoff PW.

Clin Cancer Res. 2019 Dec 3. pii: clincanres.1570.2019. doi: 10.1158/1078-0432.CCR-19-1570. [Epub ahead of print]

PMID:
31796516
3.

Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer.

Uchimoto T, Komura K, Fujiwara Y, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

Med Oncol. 2019 Nov 21;37(1):9. doi: 10.1007/s12032-019-1332-7.

PMID:
31754918
4.

Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma.

Inamoto T, Sassa N, Hattori R, Ibuki N, Komura K, Minami K, Takai T, Uchimoto T, Saito K, Tanda N, Tsujino T, Sano T, Kato M, Tsuzuki T, Gotoh M, Azuma H.

Curr Urol. 2019 Jul;12(4):201-209. doi: 10.1159/000499305. Epub 2019 Jul 20.

5.

╬▒-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in Vitro.

Taniguchi K, Wada SI, Ito Y, Hayashi J, Inomata Y, Lee SW, Tanaka T, Komura K, Akao Y, Urata H, Uchiyama K.

Mol Pharm. 2019 Nov 4;16(11):4542-4550. doi: 10.1021/acs.molpharmaceut.9b00680. Epub 2019 Oct 25.

PMID:
31596588
6.

Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.

Komura K, Fujiwara Y, Uchimoto T, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

J Clin Med. 2019 Aug 19;8(8). pii: E1251. doi: 10.3390/jcm8081251.

7.

The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.

Komura K, Hashimoto T, Tsujino T, Muraoka R, Tsutsumi T, Satake N, Matsunaga T, Yoshikawa Y, Takai T, Minami K, Taniguchi K, Uehara H, Tanaka T, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.

Ann Surg Oncol. 2019 Sep;26(9):2994-3004. doi: 10.1245/s10434-019-07530-5. Epub 2019 Jun 25.

PMID:
31240592
8.

MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.

Tsujino T, Sugito N, Taniguchi K, Honda R, Komura K, Yoshikawa Y, Takai T, Minami K, Kuranaga Y, Shinohara H, Tokumaru Y, Heishima K, Inamoto T, Azuma H, Akao Y.

Cancer Sci. 2019 Jul;110(7):2189-2199. doi: 10.1111/cas.14035. Epub 2019 May 27.

9.

C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma - A data from multi-institutional study in Japan.

Tsujino T, Komura K, Hashimoto T, Muraoka R, Satake N, Matsunaga T, Tsutsumi T, Yoshikawa Y, Takai T, Minami K, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Ohno Y, Azuma H.

Urol Oncol. 2019 Nov;37(11):812.e1-812.e8. doi: 10.1016/j.urolonc.2019.04.002. Epub 2019 Apr 30.

PMID:
31053528
10.

A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2).

Mazzu YZ, Armenia J, Chakraborty G, Yoshikawa Y, Coggins SA, Nandakumar S, Gerke TA, Pomerantz MM, Qiu X, Zhao H, Atiq M, Khan N, Komura K, Lee GM, Fine SW, Bell C, O'Connor E, Long HW, Freedman ML, Kim B, Kantoff PW.

Clin Cancer Res. 2019 Jul 15;25(14):4480-4492. doi: 10.1158/1078-0432.CCR-18-4046. Epub 2019 Apr 17.

PMID:
30996073
11.

Effect of Systematic Conversion to Generic Mycophenolate Mofetil (MMF) in Kidney Transplantation: A Single-Center Clinical Experience from Japan.

Hirano H, Matsunaga T, Maenosono R, Taniguchi S, Uehara H, Nomi H, Kano Y, Fujiwara Y, Ichihashi A, Kobayashi D, Tsutsumi T, Komura K, Ibuki N, Inamoto T, Matsumura H, Ashida A, Azuma H.

Transplant Proc. 2018 Dec;50(10):3255-3257. doi: 10.1016/j.transproceed.2018.04.064. Epub 2018 May 4.

PMID:
30577194
12.

Risk stratification by means of biological age-related factors better predicts cancer-specific survival than chronological age in patients with upper tract urothelial carcinoma: a multi-institutional database study.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

Ther Adv Urol. 2018 Nov 11;10(12):403-410. doi: 10.1177/1756287218811050. eCollection 2018 Dec.

13.

Tetramodal therapy using balloon-occluded arterial infusion of anticancer agents, the Azuma regimen, for lymph node-involved bladder cancer.

Azuma H, Inamoto T, Takahara K, Ibuki N, Nomi H, Komura K, Uehara H, Minami K, Yamamoto K, Narumi Y.

Int J Oncol. 2019 Jan;54(1):167-176. doi: 10.3892/ijo.2018.4619. Epub 2018 Nov 2.

PMID:
30387836
14.

Safety of Elderly Living Kidney Donors: 2 Cases of Donors Older Than 80 Years: A Case Report.

Hirano H, Maenosono R, Matsunaga T, Uehara H, Nomi H, Ichihashi A, Kobayashi D, Taniguchi S, Tsutsumi T, Tsujino T, Komura K, Ibuki N, Inamoto T, Azuma H.

Transplant Proc. 2018 Oct;50(8):2569-2571. doi: 10.1016/j.transproceed.2018.03.093. Epub 2018 Mar 19.

PMID:
30316400
15.

SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.

Kuranaga Y, Sugito N, Shinohara H, Tsujino T, Taniguchi K, Komura K, Ito Y, Soga T, Akao Y.

Int J Mol Sci. 2018 Oct 2;19(10). pii: E3012. doi: 10.3390/ijms19103012.

16.

A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.

Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H.

Dis Markers. 2018 Jun 20;2018:5468672. doi: 10.1155/2018/5468672. eCollection 2018.

17.

ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.

Komura K, Yoshikawa Y, Shimamura T, Chakraborty G, Gerke TA, Hinohara K, Chadalavada K, Jeong SH, Armenia J, Du SY, Mazzu YZ, Taniguchi K, Ibuki N, Meyer CA, Nanjangud GJ, Inamoto T, Lee GM, Mucci LA, Azuma H, Sweeney CJ, Kantoff PW.

J Clin Invest. 2018 Jul 2;128(7):2979-2995. doi: 10.1172/JCI96769. Epub 2018 Jun 4.

18.

Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression.

Taniguchi K, Sugito N, Shinohara H, Kuranaga Y, Inomata Y, Komura K, Uchiyama K, Akao Y.

Int J Mol Sci. 2018 Apr 24;19(5). pii: E1276. doi: 10.3390/ijms19051276.

19.

Expression of lncRNA MIR222HG co-transcribed from the miR-221/222 gene promoter facilitates the development of castration-resistant prostate cancer.

Sun T, Du SY, Armenia J, Qu F, Fan J, Wang X, Fei T, Komura K, Liu SX, Lee GM, Kantoff PW.

Oncogenesis. 2018 Mar 13;7(3):30. doi: 10.1038/s41389-018-0039-5.

20.

The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinoma.

Inamoto T, Matsuyama H, Sakano S, Ibuki N, Takahara K, Komura K, Takai T, Tsujino T, Yoshikawa Y, Minami K, Nagao K, Inoue R, Azuma H.

Oncotarget. 2017 Nov 23;8(68):113248-113257. doi: 10.18632/oncotarget.22641. eCollection 2017 Dec 22.

21.

The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma.

Tsujino T, Komura K, Ichihashi A, Tsutsumi T, Matsunaga T, Yoshikawa Y, Maenosono R, Okita K, Takai T, Oide R, Minami K, Uehara H, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

Oncotarget. 2017 Nov 25;8(66):110311-110325. doi: 10.18632/oncotarget.22688. eCollection 2017 Dec 15.

22.

Current treatment strategies for advanced prostate cancer.

Komura K, Sweeney CJ, Inamoto T, Ibuki N, Azuma H, Kantoff PW.

Int J Urol. 2018 Mar;25(3):220-231. doi: 10.1111/iju.13512. Epub 2017 Dec 20. Review.

23.

Can bladder preservation therapy come to the center stage?

Inamoto T, Ibuki N, Komura K, Juri H, Yamamoto K, Yamamoto K, Fujita K, Nonomura N, Narumi Y, Azuma H.

Int J Urol. 2018 Feb;25(2):134-140. doi: 10.1111/iju.13495. Epub 2017 Nov 23. Review.

24.

Total energy expenditure of 10- to 12-year-old Japanese children measured using the doubly labeled water method.

Komura K, Nakae S, Hirakawa K, Ebine N, Suzuki K, Ozawa H, Yamada Y, Kimura M, Ishii K.

Nutr Metab (Lond). 2017 Nov 15;14:70. doi: 10.1186/s12986-017-0226-y. eCollection 2017.

25.

Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.

Inamoto T, Matsuyama H, Ibuki N, Komura K, Takahara K, Fujimoto K, Shiina H, Sakano S, Nagao K, Miyake M, Tatsumi Y, Yasumoto H, Azuma H; Nishinihon Uro-Oncology Collaborative Group.

J Urol. 2018 Apr;199(4):933-939. doi: 10.1016/j.juro.2017.10.019. Epub 2017 Oct 14.

PMID:
29037861
26.

Spontaneous rupture of the urinary bladder (SRUB): Recovery from cardiopulmonary arrest.

Taniguchi K, Iida R, Ota K, Nitta M, Tsujino T, Komura K, Inamoto T, Azuma H, Uchiyama K, Takasu A.

Am J Emerg Med. 2017 Oct;35(10):1584.e5-1584.e7. doi: 10.1016/j.ajem.2017.07.058. Epub 2017 Jul 18.

PMID:
28751042
27.

Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.

Tsujino T, Komura K, Matsunaga T, Yoshikawa Y, Takai T, Uchimoto T, Saito K, Tanda N, Oide R, Minami K, Uehara H, Jeong SH, Taniguchi K, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

Ann Surg Oncol. 2017 Sep;24(9):2787-2793. doi: 10.1245/s10434-017-5948-6. Epub 2017 Jun 22.

PMID:
28643013
28.

Hydrogen-bridged bis(silylene) complexes of ruthenium and iron: synthesis, structures and multi-centre bonding interactions at the M-Si-H-Si four-membered ring.

Hashimoto H, Komura K, Ishizaki T, Odagiri Y, Tobita H.

Dalton Trans. 2017 Jul 11;46(27):8701-8704. doi: 10.1039/c7dt00505a.

PMID:
28304041
29.

[The stress symptoms and posttraumatic growth of dispatched firefighters following the Great East Japan Earthquake].

Yoo S, Komura K, Matsui Y, Maruyama S.

Shinrigaku Kenkyu. 2017 Feb;87(6):644-50. Japanese.

PMID:
29630302
30.

[Measuring sociosexuality: Japanese translation of the revised Sociosexual Orientation Inventory].

Nakamine S, Komura K.

Shinrigaku Kenkyu. 2016 Dec;87(5):524-34. Japanese.

PMID:
29630186
31.

MUC1-C activates BMI1 in human cancer cells.

Hiraki M, Maeda T, Bouillez A, Alam M, Tagde A, Hinohara K, Suzuki Y, Markert T, Miyo M, Komura K, Ahmad R, Rajabi H, Kufe D.

Oncogene. 2017 May 18;36(20):2791-2801. doi: 10.1038/onc.2016.439. Epub 2016 Nov 28.

32.

Synthesis, crystal structure and characterization of novel open framework CHA-type aluminophosphate involving a chiral diamine.

Komura K, Horibe Y, Yajima H, Hiyoshi N, Ikeda T.

Dalton Trans. 2016 Sep 27;45(38):15193-15202.

PMID:
27711855
33.

Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer.

Qu F, Xie W, Nakabayashi M, Zhang H, Jeong SH, Wang X, Komura K, Sweeney CJ, Sartor O, Lee GM, Kantoff PW.

Clin Cancer Res. 2017 Feb 1;23(3):726-734. doi: 10.1158/1078-0432.CCR-16-1070. Epub 2016 Aug 3.

34.

[Validation of a Japanese version of the Experience in Close Relationship- Relationship Structure].

Komura K, Murakami T, Toda K.

Shinrigaku Kenkyu. 2016 Aug;87(3):303-13. Japanese.

PMID:
29630176
35.

microRNA-145 Mediates the Inhibitory Effect of Adipose Tissue-Derived Stromal Cells on Prostate Cancer.

Takahara K, Ii M, Inamoto T, Nakagawa T, Ibuki N, Yoshikawa Y, Tsujino T, Uchimoto T, Saito K, Takai T, Tanda N, Minami K, Uehara H, Komura K, Hirano H, Nomi H, Kiyama S, Asahi M, Azuma H.

Stem Cells Dev. 2016 Sep 1;25(17):1290-8. doi: 10.1089/scd.2016.0093. Epub 2016 Aug 18.

PMID:
27465939
36.

The effect of the kindergarten barefoot policy on preschool children's toes.

Matsuda S, Kasuga K, Hanai T, Demura T, Komura K.

J Physiol Anthropol. 2016 Jul 7;36(1):4. doi: 10.1186/s40101-016-0097-3.

37.

Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression.

Komura K, Jeong SH, Hinohara K, Qu F, Wang X, Hiraki M, Azuma H, Lee GS, Kantoff PW, Sweeney CJ.

Proc Natl Acad Sci U S A. 2016 May 31;113(22):6259-64. doi: 10.1073/pnas.1600420113. Epub 2016 May 16.

38.

Prostatic Bleeding after Prostatic Biopsy Effects Oncological Outcomes with Laparoscopic Radical Prostatectomy.

Takai T, Inamoto T, Komura K, Tsujino T, Matsunaga T, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Minami K, Uehara H, Ibuki N, Takahara K, Nomi H, Kiyama S, Azuma H.

Asian Pac J Cancer Prev. 2016;17(3):1373-7.

40.

Multiple Intestinal Ulcers Associated with Primary Epstein-Barr Virus Infection in a Patient with Rheumatoid Arthritis Undergoing Methotrexate Therapy.

Makino Y, Tani C, Miyokawa N, Yoshimoto R, Mizumoto K, Eguchi K, Fujishiro D, Kodama S, Kobayashi A, Komura K, Okamoto K, Furukawa H, Haneda M.

Intern Med. 2015;54(22):2851-5. doi: 10.2169/internalmedicine.54.4735. Epub 2015 Nov 15.

41.

E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells.

Koyama K, Takahara K, Inamoto T, Ibuki N, Minami K, Uehara H, Komura K, Nishida T, Sakamoto T, Hirano H, Nomi H, Kiyama S, Azuma H.

Prostate Int. 2015 Mar;3(1):16-21. doi: 10.1016/j.prnil.2015.02.004. Epub 2015 Mar 10.

42.

Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft.

Inamoto T, Taniguchi K, Takahara K, Iwatsuki A, Takai T, Komura K, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Kouno J, Minami K, Uehara H, Hirano H, Nomi H, Kiyama S, Akao Y, Azuma H.

Oncotarget. 2015 Aug 28;6(25):21628-35.

43.

Feasibility of photodynamic diagnosis for challenging TUR- Bt cases including muscle invasive bladder cancer, BCG failure or 2nd-TUR.

Takai T, Inamoto T, Komura K, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Kouno J, Minami K, Uehara H, Takahara K, Hirano H, Nomi H, Kiyama S, Azuma H.

Asian Pac J Cancer Prev. 2015;16(6):2297-301.

44.

Periorbital lupus profundus successfully treated with oral tacrolimus plus low-dose prednisolone.

Minami-Hori M, Komatsu S, Komura K, Iizuka H, Ishida-Yamamoto A.

J Dermatol. 2015 Feb;42(2):222-3. doi: 10.1111/1346-8138.12742. Epub 2014 Dec 27. No abstract available.

PMID:
25544984
45.

Effect of voluntary hypocapnic hyperventilation on the relationship between core temperature and heat loss responses in exercising humans.

Fujii N, Honda Y, Komura K, Tsuji B, Sugihara A, Watanabe K, Kondo N, Nishiyasu T.

J Appl Physiol (1985). 2014 Dec 1;117(11):1317-24. doi: 10.1152/japplphysiol.00334.2014. Epub 2014 Sep 25.

46.

Novel bladder preservation therapy with Osaka Medical College regimen.

Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Ibuki N, Uehara H, Komura K, Minami K, Uchimoto T, Saito K, Takai T, Tanda N, Yamamoto K, Narumi Y, Kiyama S.

J Urol. 2015 Feb;193(2):443-50. doi: 10.1016/j.juro.2014.08.094. Epub 2014 Aug 26.

PMID:
25167990
47.

Cutaneous lesions of Kikuchi's disease: evolution of histopathological findings.

Kanno K, Minami-Hori M, Ishida-Yamamoto A, Komura K, Oikawa K, Miyokawa N, Iizuka H.

J Dermatol. 2014 Aug;41(8):736-8. doi: 10.1111/1346-8138.12557. Epub 2014 Jul 9.

PMID:
25040759
48.

Could transurethral resection of the prostate using the TURis system take over conventional monopolar transurethral resection of the prostate? A randomized controlled trial and midterm results.

Komura K, Inamoto T, Takai T, Uchimoto T, Saito K, Tanda N, Minami K, Uehara H, Takahara K, Hirano H, Nomi H, Kiyama S, Watsuji T, Azuma H.

Urology. 2014 Aug;84(2):405-11. doi: 10.1016/j.urology.2014.04.025. Epub 2014 Jun 21.

PMID:
24958486
49.

Incidence of urethral stricture after bipolar transurethral resection of the prostate using TURis: results from a randomised trial.

Komura K, Inamoto T, Takai T, Uchimoto T, Saito K, Tanda N, Minami K, Oide R, Uehara H, Takahara K, Hirano H, Nomi H, Kiyama S, Watsuji T, Azuma H.

BJU Int. 2015 Apr;115(4):644-52. doi: 10.1111/bju.12831. Epub 2014 Oct 24.

50.

The novel bladder preservation therapy BOAI-CDDP-radiation (OMC-regimen): a new treatment option for invasive bladder cancer patients with lymph node metastasis.

Azuma H, Inamoto T, Takahara K, Nomi H, Hirano H, Ibuki N, Uehara H, Komura K, Minami K, Uchimoto T, Saito K, Takai T, Tanda N, Yamamoto K, Narumi Y, Kiyama S.

Int J Oncol. 2014 Jun;44(6):1895-903. doi: 10.3892/ijo.2014.2378. Epub 2014 Apr 10.

PMID:
24728124

Supplemental Content

Loading ...
Support Center